Formic Acid

Formic Acid

SCHEMBL28099131

Cc1ccc(F)cn1.O=CO

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.41
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGS2 P35354 2/20 0.38
ADRA2A P08913 2/20 0.37
ADRA2B P18089 2/20 0.37
ADRA2C P18825 2/20 0.37
KDM4E B2RXH2 1/20 0.37
APLNR P35414 1/20 0.37
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29918724 0.87
SCHEMBL424656 0.87
Formaldehyde SCHEMBL28529287 0.85 TDO2 (0.41) TDO2KCNQ3KCNQ2HDAC1HDAC6
SCHEMBL30058277 0.84
Acetic Acid SCHEMBL29276427 0.83 HDAC1 (0.44) TDO2KCNQ3KCNQ2HDAC1HDAC6
Hydrochloric Acid SCHEMBL25293542 0.82 TDO2 (0.42) TDO2KCNQ3KCNQ2HDAC1HDAC6
Formic Acid SCHEMBL27887998 0.77 HDAC1 (0.41) HDAC1HDAC6SMN1; SMN2ADRA2AADRA2B
SCHEMBL13750539 0.76 TDO2 (0.46) TDO2NPC1PTGS2MAPTGRM5
Formic Acid SCHEMBL28805131 0.75 ADRA2A (0.41) HDAC1HDAC6SMN1; SMN2PTGS2ADRA2A
Formic Acid SCHEMBL31273542 0.75 KDM4E (0.46) HDAC1HDAC6ALDH1A1SMN1; SMN2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119255988-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2025-01-03 CN disclosed
CN-118339151-A Compound for inhibiting or degrading BRD9, composition and pharmaceutical application thereof 西藏海思科制药有限公司 2024-07-12 CN disclosed
CN-117881678-A Compound with SHP2 protein degradation activity and medical application thereof 尤比克斯治疗公司 2024-04-12 CN disclosed
CN-117836299-A Novel bifunctional heterocyclic compounds with Bruton tyrosine kinase decomposition via ubiquitin proteasome pathway and uses thereof 韩国化学研究院 2024-04-05 CN disclosed
CN-116490503-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-07-25 CN disclosed
CN-116354961-A Somatostatin receptor 5 antagonist, and pharmaceutical composition and application thereof 中国科学院上海药物研究所 2023-06-30 CN disclosed
CN-116157390-A Compounds for androgen receptor degradation and pharmaceutical uses thereof 尤比克斯治疗公司 2023-05-23 CN disclosed
CN-106459006-A 2,2,2-trifluoroethyl-thiadiazines 豪夫迈·罗氏有限公司 2017-02-22 CN disclosed
CN-105960405-A glutaminase inhibitors 理森制药股份公司 2016-09-21 CN disclosed